Concepedia

Martin Marciniak

MM

15

Publications

1.1K

Citations

14

H-Index

1999

Active since

Affiliations

Eli Lilly (United States)(Current)

Health Outcomes Solutions (United States)

Dana-Farber Cancer Institute

University of California, Berkeley

Harvard University

Martin Marciniak is an author at Eli Lilly (United States) specializing in medicine, depression, and public health.

Top concepts

MedicineDepressionPsychiatryPublic HealthPsychopathologyOncologyComorbidityHealth PolicyMental HealthCancer Therapy

Publications per year

1999–2016

15

Publications

15

Phase III Study of Immediate Compared With Delayed Docetaxel After Front-Line Therapy With Gemcitabine Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer

Panos Fidias, Shaker R. Dakhil, Alan P. Lyss et al. · Journal of Clinical Oncology · 2008 · 421 citations · Full text

The cost of treating anxiety: the medical and demographic correlates that impact total medical costs

Martin Marciniak, Maureen J. Lage, Eduardo Dunayevich et al. · Depression and Anxiety · 2005 · 200 citations

Post-traumatic Stress Disorder, Mental Health, Demographic Characteristics +19

Medical and productivity costs of anxiety disorders: Case control study

Martin Marciniak, Maureen J. Lage, Ronald Landbloom et al. · Depression and Anxiety · 2004 · 97 citations

Psychological Co-morbidities, Mental Health, Comorbid Psychiatric Disorder +16

Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States

Kathleen Lang, Martin Marciniak, D Faries et al. · Lung Cancer · 2008 · 55 citations

First-line Chemotherapy Use, Geriatric Oncology, Oncology +9

Neutropenia-Related Costs in Patients Treated with First-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer

Michael E. Stokes, Catherine E. Muehlenbein, Martin Marciniak et al. · Journal of Managed Care Pharmacy · 2009 · 51 citations · Full text

Rows per page

1–5 of 15